Published in Circulation on May 11, 2010
Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease. Am J Med Sci (2014) 0.93
Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of Stroke. J Am Heart Assoc (2016) 0.78
Coronary Artery Calcium Score Improves the Prediction of Occult Coronary Artery Stenosis in Ischemic Stroke Patients. J Am Heart Assoc (2016) 0.78
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update. Wien Klin Wochenschr (2016) 0.75
The inclusion of stroke in risk stratification for primary prevention of vascular events: the Northern Manhattan Study. Stroke (2011) 0.75
Authors' reply. Indian J Endocrinol Metab (2012) 0.75
Quantifying the risk of heart disease following acute ischaemic stroke: a meta-analysis of over 50 000 participants. BMJ Open (2016) 0.75
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart (2005) 9.79
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ (2007) 8.87
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA (2006) 5.95
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart (2006) 4.71
Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke (1995) 4.54
Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ (2000) 2.40
Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke (2005) 2.38
Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology (2006) 2.36
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. Nutr Metab Cardiovasc Dis (2005) 1.65
The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. Diabetes Care (2004) 1.31
Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation (2006) 1.28
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke (2009) 1.17
Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke (2002) 1.12
The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years. Am J Cardiol (2008) 1.02
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34
Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17
Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13
Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00
Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke (2008) 1.91
Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91
Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77
Infectious burden and cognitive function: the Northern Manhattan Study. Neurology (2013) 1.77
Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol (2009) 1.74
Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care (2008) 1.69
Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke (2012) 1.65
Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Circulation (2013) 1.61
Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol (2011) 1.61
CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55
Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol (2009) 1.52
Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol (2013) 1.52
Pulsatile and steady components of blood pressure and subclinical cerebrovascular disease: the Northern Manhattan Study. J Hypertens (2015) 1.48
Prevalence and quality of endodontic treatment in the Northern Manhattan elderly. J Endod (2007) 1.45
Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function. Hypertension (2012) 1.41
Diet soft drink consumption is associated with an increased risk of vascular events in the Northern Manhattan Study. J Gen Intern Med (2012) 1.37
Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med (2014) 1.34
The risk of paradoxical embolism (RoPE) study: initial description of the completed database. Int J Stroke (2012) 1.32
Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke (2012) 1.32
Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke (2004) 1.32
Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke (2009) 1.32
Construct validity of cognitive reserve in a multiethnic cohort: The Northern Manhattan Study. J Int Neuropsychol Soc (2009) 1.30
Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. Am J Epidemiol (2010) 1.26
Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke (2006) 1.25
The vascular effects of infection in Pediatric Stroke (VIPS) Study. J Child Neurol (2011) 1.23
Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart (2012) 1.23
Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J (2008) 1.22
Stochastic approximation with virtual observations for dose-finding on discrete levels. Biometrika (2009) 1.21
Septal pouch in the left atrium and risk of ischemic stroke. JACC Cardiovasc Imaging (2010) 1.20
Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). Atherosclerosis (2011) 1.17
The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol. Stroke (2013) 1.14
Social determinants of physical inactivity in the Northern Manhattan Study (NOMAS). J Community Health (2010) 1.14
Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke (2013) 1.14
Intravenous thrombolytic treatment of acute ischemic stroke associated with left atrial myxoma: a case report. J Stroke Cerebrovasc Dis (2007) 1.13
Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis (2009) 1.13
Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis (2007) 1.13
Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke (2012) 1.13
Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. Eur J Heart Fail (2010) 1.12
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke (2013) 1.11
Outpatient training in neurology: history and future challenges. Neurology (2006) 1.10
Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09
Early depressed mood after stroke predicts long-term disability: the Northern Manhattan Stroke Study (NOMASS). Stroke (2010) 1.09
The growing problem of stroke among young adults. Curr Cardiol Rep (2013) 1.09
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
Daytime sleepiness and risk of stroke and vascular disease: findings from the Northern Manhattan Study (NOMAS). Circ Cardiovasc Qual Outcomes (2012) 1.08
LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. JACC Cardiovasc Imaging (2013) 1.08
Recent developments regarding human immunodeficiency virus infection and stroke. Cerebrovasc Dis (2012) 1.07
Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome. Ann Neurol (2014) 1.06
Endothelial dysfunction is associated with carotid plaque: a cross-sectional study from the population based Northern Manhattan Study. BMC Cardiovasc Disord (2006) 1.05
Lipids and carotid plaque in the Northern Manhattan Study (NOMAS). BMC Cardiovasc Disord (2009) 1.04
The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease. J Neurosurg (2009) 1.04
Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet (2015) 1.03
Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke (2011) 1.03
Adiponectin and carotid intima-media thickness in the northern Manhattan study. Stroke (2011) 1.02
Alterations in plasma complement levels after human ischemic stroke. Neurosurgery (2006) 1.00
Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume: the northern Manhattan study. Stroke (2011) 1.00
Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. J Neurosurg (2009) 1.00
Impact of delayed transfer of critically ill stroke patients from the Emergency Department to the Neuro-ICU. Neurocrit Care (2010) 0.99
Dietary total fat intake and ischemic stroke risk: the Northern Manhattan Study. Neuroepidemiology (2009) 0.99
Radiographic measures of chronic periodontitis and carotid artery plaque. Stroke (2005) 0.98
The contribution of HIV infection to intracranial arterial remodeling: a pilot study. Neuropathology (2012) 0.97
A questionable cause of intracerebral hemorrhage. JAMA Neurol (2013) 0.97
Mediterranean diet and white matter hyperintensity volume in the Northern Manhattan Study. Arch Neurol (2012) 0.97
Cardiovascular health status among Caribbean Hispanics living in Northern Manhattan and Ecuadorian natives/mestizos in rural coastal Ecuador: a comparative study. J Community Health (2013) 0.97
Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther (2011) 0.95
Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan Study. Am Heart J (2011) 0.95
Ethnic differences in carotid artery diameter and stiffness: the Northern Manhattan Study. Atherosclerosis (2011) 0.95
Snoring and insomnia are not associated with subclinical atherosclerosis in the Northern Manhattan Study. Int J Stroke (2010) 0.95
High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study. Stroke (2014) 0.95
Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms. Int J Stroke (2011) 0.94
Relationship of multidirectional myocardial strain with radial thickening and ejection fraction and impact of left ventricular hypertrophy: a study in a community-based cohort. Echocardiography (2013) 0.94
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). Neurology (2014) 0.94
Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox. Ann Epidemiol (2012) 0.93
Association between sleep duration and the mini-mental score: the Northern Manhattan study. J Clin Sleep Med (2013) 0.93
Reported alcohol consumption and cognitive decline: The northern Manhattan study. Neuroepidemiology (2006) 0.91
Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population. J Nutr (2013) 0.90
Moderate alcohol consumption is associated with better endothelial function: a cross sectional study. BMC Cardiovasc Disord (2009) 0.90
Sleep duration is associated with white matter hyperintensity volume in older adults: the Northern Manhattan Study. J Sleep Res (2014) 0.90
Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study. Age Ageing (2013) 0.89
Ethnic differences in aortic valve thickness and related clinical factors. Am Heart J (2010) 0.89
Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study. Cerebrovasc Dis (2014) 0.88
The metabolic syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study. J Cardiometab Syndr (2007) 0.88